APA (7th ed.) Citation

Queille-Roussel, C., Nielsen, J., & Lacour, J. (2019). Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris. Journal of Dermatological Treatment, 30(6), 529. https://doi.org/10.1080/09546634.2018.1529385

Chicago Style (17th ed.) Citation

Queille-Roussel, C., J. Nielsen, and J.-P Lacour. "Vasoconstrictor Potency of Fixed-dose Combination Calcipotriol (50 μg/g) and Betamethasone Dipropionate (0.5 Mg/g) Cutaneous Foam Versus Other Topical Corticosteroids Used to Treat Psoriasis Vulgaris." Journal of Dermatological Treatment 30, no. 6 (2019): 529. https://doi.org/10.1080/09546634.2018.1529385.

MLA (9th ed.) Citation

Queille-Roussel, C., et al. "Vasoconstrictor Potency of Fixed-dose Combination Calcipotriol (50 μg/g) and Betamethasone Dipropionate (0.5 Mg/g) Cutaneous Foam Versus Other Topical Corticosteroids Used to Treat Psoriasis Vulgaris." Journal of Dermatological Treatment, vol. 30, no. 6, 2019, p. 529, https://doi.org/10.1080/09546634.2018.1529385.